Humans Male Prostatectomy/methods/standards Prostatic Hyperplasia/complications Urethral Obstruction/etiology Benign prostate hyperplasia Benign prostatic obstruction Chirurgie Guidelines Hyperplasie bénigne prostate Interventional management Lower urinary tract symptoms Obstruction sous-vésicale Recommandations Surgery Symptômes du bas appareil urinaire Traitement interventionnel

Bladder Cancer Imaging surgical Treatment pathology Management follow-up radiation Therapy systemic Therapy

Guidelines Benign prostate hyperplasia Benign prostatic obstruction Lower urinary tract symptoms Surgery Interventional management

Bladder Cancer Management Consensus

Muscle-invasive Bladder Cancer Management Consensus

Bladder Cancer Management Non-muscle-invasive Bladder Cancer Oncology Risk Factors

Bladder Cancer Disease Management Follow-up Guidelines Muscle Invasive

Endoscopic bladder cancer follow-up surveillance form (available at http://dx.doi.org/10.21037/tau-20-1363). The series “Expectant Management in Genitourinary Malignancies (Prostate Bladder Kidney)” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.

Quality of life (QoL) bladder cancer non-muscle invasive bladder cancer (NMIBC) surveillance form (available at http://dx.doi.org/10.21037/tau-20-1333). The series “Expectant Management in Genitourinary Malignancies (Prostate Bladder Kidney)” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.

Anesthetics Local/*therapeutic use *Cystoscopy Humans Lidocaine/*therapeutic use Male Pain Management/*methods Pain Measurement Randomized Controlled Trials as Topic Urinary Bladder Neoplasms/diagnosis/therapy administration cystoscopy intravesical lidocaine pain procedural urinary bladder neoplasms

Carcinoma Transitional Cell/diagnosis/epidemiology/*therapy Child Combined Modality Therapy *Disease Management Disease Progression Global Health Humans Incidence Risk Factors Survival Rate/trends Urinary Bladder/*pathology Urinary Bladder Neoplasms/diagnosis/epidemiology/*therapy Management Pediatric Surveillance Transurethral resection Urothelial cell carcinoma